aiming to add eight new cancer blockbusters to its current roster of five before the end of the decade. Chris Boshoff, Pfizer’s chief oncology officer Its new chief oncology officer, Dr Chris ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

The world’s largest group of oil producers, OPEC+, stuck to its guns on Saturday with another big increase of 411,000 barrels per day for July as it looks to wrestle back market share and punish ...